PolarCool

The med-tech company PolarCool AB (publ) continues its successful expansion in international rugby by signing an agreement with Portugal's National Rugby Team. The partnership provides the Portuguese national team access to the PolarCap® System during the 2023 Rugby World Cup in France and throughout the following rugby season.

PolarCool develops and markets the product PolarCap®, which alleviates the effects of concussion. The primary users of PolarCap® include sports clubs, organizations, and facilities in contact sports such as ice hockey, rugby, football, and handball, but also other sports with an increased risk of concussion.

PolarCool has had several successes in international rugby. The agreement with Portugal Rugby will be the third in a series of nations to sign agreements enabling them to provide treatment with PolarCap® System. The company has recently partnered with Rugby Australia and Georgia Rugby, who together with Portugal Rugby will provide the PolarCap® System during the 2023 Rugby World Cup.

Portugal Rugby Chief Medical Officer, Dr António Cruz Ferreira comments;

-As the medical doctor for Portugal Rugby, I am looking forward to getting first-hand experience of the PolarCap® System. We have evaluated the clinical evidence for the treatment and welcome new innovations aimed at improving the acute management of concussions.

PolarCool CEO Erik Andersson comments;

-We have actively worked on the international rugby market to establish the PolarCap® System. It is very gratifying that we now see the results of the extensive efforts we carried out during the year. We now look forward to continuing this successful momentum within professional rugby.

The agreements align with PolarCool's overall strategy to introduce the treatment to the professional rugby market. The agreement is strategically important, even if the financial impact of individual agreements is limited.